ImageneBio IMA Institutional Ownership

Updated Oct 11, 2026

ImageneBio, Inc. (NASDAQ:IMA) had 36 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• Together they owned 39.17% of the outstanding stock in Q2 2026, down from 47.48% a quarter earlier.
• Total holdings of IMA shares rose 18.21% from Q1 2026, and the holder count fell 5.26% from Q2 2025.
• Among the 36 holders of ImageneBio, 15 added to their positions, 12 reduced their stakes and 9 left their positions unchanged.
• The aggregate institutional position in ImageneBio was 6.33Mn shares at the end of Q2 2026, up 975.04K from the prior quarter and up 3.7Mn from a year earlier.
• BVF Inc was the top holder of ImageneBio as of June 30, 2026, with 1.11Mn shares, or 6.87% of shares outstanding.
• The biggest increases in IMA positions during Q2 2026 came from OrbiMed Advisors LLC (+530.71K shares), Cable Car Capital, LP (+26.85K shares), Nano Cap New Millennium Growth Fund L.P. (+20K shares), BlackRock, Inc. (+5.88K shares) and Renaissance Technologies LLC (+5.23K shares).
• The biggest cuts to IMA positions during Q2 2026 came from Citadel Advisors LLC (-68.73K shares), Blue Owl Capital Holdings LP (-41.65K shares), Rangeley Capital, LLC (-12.5K shares), Geode Capital Management, LLC (-6.42K shares) and Vanguard Capital Management LLC (-4.64K shares).
• Per Business Quant, the top 10 investors in IMA for the quarter ended June 30, 2026 were BVF Inc (1.11Mn shares), Blue Owl Capital Holdings LP (917.69K shares), OrbiMed Advisors LLC (909.27K shares), Cable Car Capital, LP (781.6K shares), Omega Fund Management, LLC (455.36K shares), RTW Investments, LP (334.44K shares), Vanguard Capital Management LLC (320.52K shares), Trails Edge Capital Partners, LP (282K shares), BML Capital Management, LLC (200.73K shares) and Monashee Investment Management LLC (192.34K shares).